DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.

about

Increased DCLK1 correlates with the malignant status and poor outcome in malignant tumors: a meta-analysis.

P2860

Q47136464-C1768D4A-E50F-42FF-BDE5-C8EBD7A1D4AD

P2860

DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.

Item

http://www.wikidata.org/entity/Q50941345

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.

@en

DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.

@nl

type

Item

label

DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.

@en

DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.

@nl

prefLabel

DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.

@en

DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.

@nl

P1476

DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.

@en

P2093

Guoqing Zhang

http://www.w3.org/2001/XMLSchema#string

Hongbo Guo

http://www.w3.org/2001/XMLSchema#string

Shiqing Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

DCAMKL1, a brain-specific transmembrane protein on 13q12.3 that is similar to doublecortin (DCX)

Global cancer statistics, 2012

Vascular endothelial growth factor and its correlation with superficial bladder cancer recurrence rates and stage progression.

Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas.

DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer.

Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice.

DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.

DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma

Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism.

Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications

P304

1010428317703822

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1010428317703822

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28621231

http://www.w3.org/2001/XMLSchema#string

DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.

about

P2860

P2860

DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698